An Open Label Phase IB study of PF-04449913 (Glasdegib) in Combination with Azacitidine in patients with previously untreated higher-risk myelodysplastic syndrome, acute myeloid leukemia

Administered By

Awarded By

Contributors

Start/End

  • July 9, 2018 - July 31, 2023